| LCMRX | PEMGX | LCMRX / PEMGX | |
| Total Expense Ratio | 1.45 | 0.91 | 159% |
| Annual Report Gross Expense Ratio | 1.57 | 0.91 | 173% |
| Fund Existence | 12 years | 21 years | - |
| Gain YTD | -1.373 | -1.964 | 70% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 279M | 29.5B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -11.50 | -10.15 | 113% |
| Returns for 3 years | 26.68 | 21.59 | 124% |
| Returns for 5 years | 3.68 | 12.32 | 30% |
| Returns for 10 years | 96.90 | 117.81 | 82% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 85.24 | 0.43 | +0.51% |
| ProShares Ultra Nasdaq Biotechnology | |||
| TDTT | 24.13 | -0.03 | -0.12% |
| FlexShares iBoxx 3Yr Target Dur TIPS ETF | |||
| KNOV | 29.28 | -0.17 | -0.57% |
| Innovator U.S. Small Cp Pwr Buf ETF -Nov | |||
| GMF | 143.18 | -1.16 | -0.80% |
| State Street® SPDR® S&P® Em AsiaPac ETF | |||
| SKRE | 7.21 | -0.23 | -3.15% |
| Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF | |||